3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin) & Research (Regenerative Medicine)) - Global Forecasts to 2021

Table of Contents

1 INTRODUCTION 14

1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 15
1.4 MARKETS COVERED 15
1.5 YEARS CONSIDERED FOR THE STUDY 16
1.6 CURRENCY 16
1.7 LIMITATIONS 16
1.8 STAKEHOLDERS 17

2 RESEARCH METHODOLOGY 18

2.1 RESEARCH METHODOLOGY STEPS 18
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 19
2.1.1.1 Secondary research 19
2.1.1.2 Key data from secondary sources 19
2.1.1.3 Primary research 20
2.1.1.4 Key data from primary sources 21
2.1.1.5 Key Industry Insights 22
2.2 MARKET SIZE ESTIMATION METHODOLOGY 22
2.3 RESEARCH DESIGN 24
2.4 MARKET DATA VALIDATION AND TRIANGULATION 25
2.5 ASSUMPTIONS FOR THE STUDY 26

3 EXECUTIVE SUMMARY 27

3.1 INTRODUCTION 27
3.2 CONCLUSION 31

4 PREMIUM INSIGHTS 32

4.1 3D BIOPRINTING: MARKET OVERVIEW 32
4.2 GEOGRAPHIC ANALYSIS: 3D BIOPRINTING MARKET, BY TECHNOLOGY (2016) 33
4.3 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2016 VS. 2021 (USD MILLION) 33
4.4 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION) 34
4.5 GEOGRAPHIC SNAPSHOT OF THE 3D BIOPRINTING MARKET 34

5 MARKET OVERVIEW 35

5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Growing demand for organ transplantation 37
5.2.1.2 Rise in public and private funding to support 3D bioprinting research activities 37
5.2.1.3 Increasing use of 3D bioprinting in the drug discovery process 38
5.2.1.4 Growing focus of market players on 3D bioprinting 38
5.2.2 RESTRAINTS 39
5.2.2.1 Lack of regulatory guidelines governing 3D bioprinting 39
5.2.2.2 Dearth of trained professionals 39
5.2.3 OPPORTUNITIES 40
5.2.3.1 Increasing stem cell research 40
5.2.3.2 Growing awareness related to 3D bioprinting 41
5.2.3.3 Rising adoption of 3D bioprinting in the cosmetic industry 41
5.2.4 CHALLENGES 42
5.2.4.1 Socio-ethical concerns related to the use of 3D bioprinted products 42
5.2.4.2 Limitations of biomaterial-based products 42
5.2.4.3 Lack of complete automation 42

6 INDUSTRY INSIGHTS 43

6.1 INTRODUCTION 43
6.2 3D BIOPRINTING APPROACHES 43
6.2.1 BIOMIMICRY 43
6.2.2 AUTONOMOUS SELF-ASSEMBLY 43
6.2.3 MINI-TISSUE BUILDING BLOCKS 43
6.3 3D BIOPRINTING PATENT LANDSCAPE 44
6.4 INDUSTRY TRENDS 45
6.4.1 FUNDING AND INVESTMENTS 45
6.4.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 45
6.4.3 CONFERENCES AND SYMPOSIUMS 46

7 3D BIOPRINTING MARKET, BY TECHNOLOGY 47

7.1 INTRODUCTION 48
7.2 MAGNETIC 3D BIOPRINTING 49
7.3 LASER-ASSISTED BIOPRINTING 50
7.4 INKJET 3D BIOPRINTING 52
7.5 MICROEXTRUSION BIOPRINTING 54

8 3D BIOPRINTING MARKET, BY MATERIAL 56

8.1 INTRODUCTION 57
8.2 HYDROGELS 58
8.3 EXTRACELLULAR MATRICES 59
8.4 LIVING CELLS 61
8.5 OTHER BIOMATERIALS 62
 

9 3D BIOPRINTING MARKET, BY APPLICATION 64

9.1 INTRODUCTION 65
9.2 CLINICAL APPLICATIONS 66
9.2.1 SKIN 68
9.2.2 BONE & CARTILAGE 69
9.2.3 BLOOD VESSELS 69
9.3 RESEARCH APPLICATIONS 70
9.3.1 DRUG RESEARCH 72
9.3.2 REGENERATIVE MEDICINE 73
9.3.3 3D CELL CULTURE 73

10 3D BIOPRINTING MARKET, BY REGION 75

10.1 INTRODUCTION 76
10.2 NORTH AMERICA 78
10.2.1 U.S. 80
10.2.2 CANADA 83
10.3 EUROPE 85
10.3.1 GERMANY 87
10.3.2 FRANCE 89
10.3.3 U.K. 91
10.3.4 REST OF EUROPE (ROE) 93
10.4 ASIA-PACIFIC 95
10.4.1 JAPAN 97
10.4.2 CHINA 99
10.4.3 INDIA 101
10.4.4 REST OF ASIA-PACIFIC 103
10.5 REST OF THE WORLD (ROW) 105

11 COMPETITIVE LANDSCAPE 107

11.1 OVERVIEW 107
11.2 MARKET RANKING ANALYSIS 108
11.3 COMPETITIVE SITUATION AND TRENDS 109
11.3.1 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS 109
11.3.2 PRODUCT LAUNCHES, DEVELOPMENTS, AND COMMERCIALIZATION 110
11.3.3 PRODUCT SHOWCASES, EXHIBITIONS, AND PRESENTATIONS 111
11.3.4 FUNDING 112
11.3.5 OTHER STRATEGIES 113
 

12 COMPANY PROFILES 114

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION 114
12.2 ORGANOVO HOLDINGS, INC. 115
12.3 ENVISIONTEC GMBH 119
12.4 NANO3D BIOSCIENCES, INC. 121
12.5 CYFUSE BIOMEDICAL K.K. 124
12.6 REGENHU LTD. 126
12.7 ASPECT BIOSYSTEMS LTD. 127
12.8 BIOBOTS 128
12.9 CELLINK 129
12.10 GESIM 130
12.11 POIETIS 131
12.12 REGENOVO BIOTECHNOLOGY CO., LTD. 133
12.13 3DYNAMIC SYSTEMS LTD. 134

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 135

LIST OF TABLES

TABLE 1 3D BIOPRINTING PATENTS, 2015–2016 44
TABLE 2 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 48
TABLE 3 MAGNETIC 3D BIOPRINTING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 50
TABLE 4 LASER-ASSISTED 3D BIOPRINTING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 51
TABLE 5 INKJET 3D BIOPRINTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 53
TABLE 6 MICROEXTRUSION 3D BIOPRINTING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 55
TABLE 7 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION) 57
TABLE 8 HYDROGELS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 59
TABLE 9 EXTRACELLULAR MATRICES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 60
TABLE 10 LIVING CELLS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 62
TABLE 11 OTHER BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 63
TABLE 12 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 65
TABLE 13 CLINICAL APPLICATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 66
TABLE 14 CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 67
TABLE 15 SKIN BIOPRINTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 68
TABLE 16 BONE & CARTILAGE BIOPRINTING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 69
TABLE 17 BLOOD VESSEL BIOPRINTING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 70
TABLE 18 RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 71
TABLE 19 RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 71
TABLE 20 DRUG RESEARCH MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 72
TABLE 21 REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 73
TABLE 22 3D CELL CULTURE MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 74
TABLE 23 3D BIOPRINTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 77
TABLE 24 NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 78
TABLE 25 NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 78
TABLE 26 NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 80
TABLE 27 NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 80
TABLE 28 U.S.: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 82
TABLE 29 U.S.: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 82
TABLE 30 U.S.: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 82
TABLE 31 CANADA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 83
TABLE 32 CANADA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 84
TABLE 33 CANADA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 84
TABLE 34 EUROPE: 3D BIOPRINTING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 85
TABLE 35 EUROPE: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 85
TABLE 36 EUROPE: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 87
TABLE 37 EUROPE: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 87
TABLE 38 GERMANY: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 88
TABLE 39 GERMANY: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 88
TABLE 40 GERMANY: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 89
TABLE 41 FRANCE: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 90
TABLE 42 FRANCE: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 90
TABLE 43 FRANCE: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 90
TABLE 44 U.K.: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 92
TABLE 45 U.K.: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 92
TABLE 46 U.K.: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 92
TABLE 47 ROE: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 94
TABLE 48 ROE: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 94
TABLE 49 ROE: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 94
TABLE 50 ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 95
TABLE 51 ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 95
TABLE 52 ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 97
TABLE 53 ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 97
TABLE 54 JAPAN: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 98
TABLE 55 JAPAN: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 98
TABLE 56 JAPAN: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 99
TABLE 57 CHINA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 100
TABLE 58 CHINA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 100
TABLE 59 CHINA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 100
TABLE 60 INDIA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 101
TABLE 61 INDIA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 102
TABLE 62 INDIA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 102
TABLE 63 ROAPAC: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 103
TABLE 64 ROAPAC: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 104
TABLE 65 ROAPAC: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 104
TABLE 66 ROW: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 106
TABLE 67 ROW: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 106
TABLE 68 ROW: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 106
TABLE 69 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016 109
TABLE 70 TOP 5 PRODUCT LAUNCHES, DEVELOPMENTS, AND COMMERCIALIZATION,
2013–2016 110
TABLE 71 PRODUCT SHOWCASES, EXHIBITIONS, AND PRESENTATIONS, 2013–2016 111
TABLE 72 TOP 5 FUNDING, 2013–2016 112
TABLE 73 OTHER STRATEGIES, 2013–2016 113
TABLE 74 PRODUCT MIX OF THE 3D BIOPRINTER MARKET PLAYERS 114

LIST OF FIGURES

FIGURE 1 GLOBAL 3D BIOPRINTING MARKET: RESEARCH METHODOLOGY STEPS 18
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 3 RESEARCH METHODOLOGY: BOTTOM-UP APPROACH 23
FIGURE 4 RESEARCH METHODOLOGY: TOP-DOWN APPROACH 23
FIGURE 5 DATA TRIANGULATION METHODOLOGY 24
FIGURE 6 DATA TRIANGULATION METHODOLOGY 25
FIGURE 7 GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY 28
FIGURE 8 GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION 28
FIGURE 9 GLOBAL 3D BIOPRINTING MARKET, BY MATERIAL 29
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE GLOBAL 3D BIOPRINTING MARKET 30
FIGURE 11 RISING DEMAND FOR ORGAN TRANSPLANTATION IS DRIVING GROWTH IN THE 3D BIOPRINTING MARKET 32
FIGURE 12 MICROEXTRUSION 3D BIOPRINTING TO DOMINATE THE GLOBAL 3D BIOPRINTING MARKET IN 2016 33
FIGURE 13 LIVING CELLS TO COMMAND THE LARGEST SHARE IN THE 3D BIOPRINTING MARKET IN 2016 33
FIGURE 14 RESEARCH APPLICATIONS WILL CONTINUE TO DOMINATE THE GLOBAL 3D BIOPRINTING MARKET IN 2021 34
FIGURE 15 NORTH AMERICA TO COMMAND THE LARGEST SHARE IN THE GLOBAL 3D BIOPRINTING MARKET IN 2016 34
FIGURE 16 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36
FIGURE 17 MICROEXTRUSION 3D BIOPRINTING SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 48
FIGURE 18 ASIA-PACIFIC TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 49
FIGURE 19 NORTH AMERICA TO HOLD A MAJOR SHARE IN THE LASER-ASSISTED 3D BIOPRINTING MARKET 51
FIGURE 20 ASIA-PACIFIC TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 53
FIGURE 21 NORTH AMERICA TO HOLD A MAJOR SHARE IN THE MICROEXTRUSION 3D BIOPRINTING MARKET 54
FIGURE 22 LIVING CELLS SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 57
FIGURE 23 NORTH AMERICA TO HOLD THE LARGEST SHARE IN THE HYDROGELS MARKET, IN 2016 AND 2021 58
FIGURE 24 ASIA-PACIFIC SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 60
FIGURE 25 NORTH AMERICA TO HOLD THE LARGEST SHARE IN THE LIVING CELLS MARKET DURING THE FORECAST PERIOD 61
FIGURE 26 NORTH AMERICA TO HOLD LARGEST SHARE OF THE OTHER BIOMATERIALS MARKET IN 2016 63
FIGURE 27 RESEARCH APPLICATIONS SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 65
FIGURE 28 SKIN SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 66
FIGURE 29 NORTH AMERICA TO COMMAND LARGEST SHARE DURING THE FORECAST PERIOD 67
FIGURE 30 DRUG RESEARCH SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 70
FIGURE 31 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 71
FIGURE 32 3D BIOPRINTING MARKET: GROWTH FORECAST, BY REGION (2016–2021) 76
FIGURE 33 NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT 79
FIGURE 34 EUROPE: 3D BIOPRINTING MARKET SNAPSHOT 86
FIGURE 35 APAC: 3D BIOPRINTING MARKET SNAPSHOT 96
FIGURE 36 LEADING MARKET PLAYERS ADOPTED AGREEMENT, COLLABORATION, AND PARTNERSHIP AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS (2013–2016) 107
FIGURE 37 GLOBAL 3D BIOPRINTING MARKET RANKING, BY KEY PLAYER, 2015 108
FIGURE 38 BATTLE FOR MARKET SHARE: AGREEMENT, COLLABORATION, AND PARTNERSHIP WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS 109
FIGURE 39 COMPANY SNAPSHOT: ORGANOVO HOLDINGS, INC. 115

当レポートのプレスリリースは発行されておりません。